Search Within

Jacqueline Bromberg

Formats
  1. Journal Article (93)
  2. Meeting Abstract (49)
  3. Book Section (2)
Groups
  1. Breast Medicine Service (144)
  2. Department of Medicine (144)
  3. GSK Faculty (144)
  4. Solid Tumor Oncology Division (144)
  5. Sloan Kettering Institute Postdocs (51)
  6. Survivorship Research (39)

More Groups

People
  1. Shanu Modi (21)
  2. Larry Norton (20)
  3. Tiffany Traina (17)
  4. David Lyden (16)
  5. Chau Dang (15)
  6. Clifford Hudis (15)

More People

Years
  1. 2025 (4)
  2. 2024 (8)
  3. 2023 (3)
  4. 2022 (8)
  5. 2021 (3)
  6. 2020 (10)

More Years

Publications
  1. Cancer Research (24)
  2. Journal of Clinical Oncology (12)
  3. Proceedings of the National Academy of Sciences of the United States of America (8)
  4. Journal of Vascular and Interventional Radiology (6)
  5. Annals of Oncology (5)
  6. Clinical Cancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (31)
  2. Nature Publishing Group (16)
  3. American Society of Clinical Oncology (13)
  4. Elsevier Inc. (11)
  5. Oxford University Press (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation
    Journal Article

    Leslie, K.; Gao, S. P.; Berishaj, M.; Podsypanina, K.; Ho, H.; Ivashkiv, L.; Bromberg, J.
    Breast Cancer Research (2010)

    Fulltext@MSK | Save
  • Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis
    Journal Article

    Koppikar, P.; Abdel-Wahab, O.; Hedvat, C.; Marubayashi, S.; Patel, J.; Goel, A.; Kucine, N.; Gardner, J. R.; Combs, A. P.; Vaddi, K.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Inflammation and cancer: IL-6 and STAT3 complete the link
    Journal Article

    Bromberg, J.; Wang, T. C.
    Cancer Cell (2009)

    Fulltext@MSK | Save
  • Mutations in the EGFR kinase domain mediate Stat3 activation via IL-6 production in human lung adenocarcinomas
    Meeting Abstract

    Gao, S. P.; Mark, K. G.; Leslie, K.; Pao, W.; Motoi, N.; Gerald, W. L.; Travis, W. D.; Bornmann, W.; Veach, D.; Clarkson, B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Tris (dibenzylideneacetone) dipalladium (Tris DBA), an N-myristoyltransferase 1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Meeting Abstract

    Arbiser, I. L.; Bhandarkar, S.; Bromberg, J.; Selvakumar, P.; Sharma, R. K.; Fried, L.; Govindarajan, B.
    Journal of Investigative Dermatology (2008)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness
    Journal Article

    De La Iglesia, N.; Konopka, G.; Lim, K. L.; Nutt, C. L.; Bromberg, J. F.; Frank, D. A.; Mischel, P. S.; Louis, D. N.; Bonni, A.
    The Journal of Neuroscience (2008)

    Fulltext@MSK | Save
  • Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Journal Article

    Bhandarkar, S. S.; Bromberg, J.; Carrillo, C.; Selvakumar, P.; Sharma, R. K.; Perry, B. N.; Govindarajan, B.; Fried, L.; Sohn, A.; Reddy, K.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save